Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

America’s Biopharmaceutical Companies Unveil TV Ad Showcasing New World of Medicine

May 15, 2017

PhRMA unveiled its latest advertisement as part of its groundbreaking GOBOLDLY™ campaign, titled New World, featuring some of the most extraordinary breakthroughs in science being discovered by biopharmaceutical researchers.

Read More

PhRMA Statement Following Meeting With HHS Secretary Price

May 12, 2017

PhRMA president and CEO Stephen J. Ubl issued a statement following a meeting with HHS Secretary Price.

Read More

Former law enforcement officials raise concerns with drug importation proposals

May 11, 2017

Several former law enforcement officials have recently expressed concerns with drug importation schemes, like those proposed by some members of Congress.

Read More

Why won’t the insurance industry tell the truth about medicine costs?

May 10, 2017

Unfortunately, the insurance industry is continuing to advance a false and misleading narrative about prescription medicine cost growth.

Read More

PhRMA Board of Directors Establishes New Membership Criteria

May 9, 2017

Demonstrating its commitment to representing research- based biopharmaceutical companies, the board of directors for the Pharmaceutical Research and Manufacturers of America (PhRMA) today approved new criteria for membership.

Read More

Government-imposed price controls threaten innovation and access

May 9, 2017

It’s no coincidence that America leads the world in the discovery and development of new lifesaving medicines.

Read More

ICYMI: Innovative payment models helping provide patient access to new medicines

May 5, 2017

The biopharmaceutical industry is committed to advancing policy ideas to find innovative ways to pay for medicines.

Read More

Guest Post: The Clinical trial experience from a patient & researcher perspective

May 5, 2017

Patients like myself are helping fuel the next era of medicine through participation in clinical trials across the country.

Read More

ICYMI: Ubl weighs in on how fair trade protects US biopharmaceutical innovation

May 5, 2017

America’s biopharmaceutical leadership is a result of a robust medical innovation ecosystem driven by several factors

Read More

4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report

May 4, 2017

We have seen a deluge of data recently from government actuaries and pharmacy benefit managers showing a dramatic slowdown in medicine spending growth.

Read More